ReviewInternational journal of molecular sciences2020

Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment.

Laurène Fenwarth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.